Maxcyte (MXCT) EBT Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | 12,945.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,945.00 |
| Dec 31, 2025 | 32,312.00 |
| Sep 30, 2025 | -4,025.00 |
| Jun 30, 2025 | -2,331.00 |
| Mar 31, 2025 | -808.00 |
| Dec 31, 2024 | -1,093.00 |
| Sep 30, 2024 | 12,916.00 |
| Jun 30, 2024 | -7,262.00 |
| Mar 31, 2024 | 4,862.00 |
| Dec 31, 2023 | -26,663.00 |
| Sep 30, 2023 | -18,077.00 |
| Jun 30, 2023 | -3,027.00 |
| Mar 31, 2023 | -18,412.00 |
| Dec 31, 2022 | -6,890.00 |
| Sep 30, 2022 | -4,216.00 |
| Jun 30, 2022 | -2,377.00 |
| Mar 31, 2022 | 13,252.00 |
| Dec 31, 2021 | 49,339.00 |
| Sep 30, 2021 | 1,857.00 |
| Jun 30, 2021 | 6,693.00 |